---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-026257"
form_type: "8-K"
ticker: "CLNN"
cik: "0001822791"
company_name: "Clene Inc."
filed_at: "2023-09-19T23:59:59+00:00"
generated_at: "2026-06-10T13:45:21.219324+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Clene appoints Prof. Kiernan and Dr. Desai to Board; Dr. Stevens retires

## Summary
- Appointed Prof. Matthew Kiernan (neurology chair, University of Sydney) and Dr. Arjun Desai (INSIGHTEC exec) as Class II directors.
- Each received 45,000 common stock options at $0.54 exercise price, vesting monthly over 36 months.
- Director John H. Stevens retired immediately, not due to any disagreement; he served since 2015.
- Jonathon T. Gay joined Audit Committee; Dr. Desai joined Compensation Committee.

## SEC filing metadata
- accession: 0001437749-23-026257
- form_type: 8-K
- ticker: CLNN
- cik: 0001822791
- company_name: Clene Inc.
- filed_at: 2023-09-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822791/000143774923026257/0001437749-23-026257-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822791/000143774923026257/clnn20230914_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-026257
- JSON: https://secwatch.observer/filing/0001437749-23-026257.json
- Plain text: https://secwatch.observer/filing/0001437749-23-026257.txt

## Key facts
- Executive change
  John H. Stevens retired as Class II Director at Clene Inc..
  - Action: retired
  - Role: Class II Director
  source text: John H. Stevens, M.D., a Class II director of the Company, informed the Board of his decision to retire from the Board and all committees
  evidence_url: https://www.sec.gov/Archives/edgar/data/1822791/000143774923026257/0001437749-23-026257-index.htm
- Executive change
  Matthew Kiernan was appointed as Class II Director at Clene Inc..
  - Action: appointed
  - Role: Class II Director
  source text: appointed Professor Matthew Kiernan AM, Ph.D., DSc, and Arjun (JJ) Desai, M.D., as members of the Board, effective September 18, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1822791/000143774923026257/0001437749-23-026257-index.htm
- Executive change
  Arjun Desai was appointed as Class II Director at Clene Inc..
  - Action: appointed
  - Role: Class II Director
  source text: appointed Professor Matthew Kiernan AM, Ph.D., DSc, and Arjun (JJ) Desai, M.D., as members of the Board, effective September 18, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1822791/000143774923026257/0001437749-23-026257-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.